TABLE 3.
Therapeutic agents | Delivery systems | Target genes | Tumor cell lines | References |
---|---|---|---|---|
siCCL18 | NP‐180 | CCL18 | MDA‐MB‐231 | 169 |
siCCR2 | CNP/siCCR2 | CCR2 | 4T1 | 170 |
siMIF | Glucan‐based siRNA carrier | MIF | MDA‐MB‐231/ 4T1 | 171 |
siVEGF + siPIGF | PEG=MT/PC/siVEGF siPIGF NPs | VEGF and PIGF | 4T1 | 172 |
VEGF inhibitor + siMED1 | MT/PC/siV‐D NPs | VEGF and MED1 | 4T1 | 173 |
CRISPR‐RICTOR | CRISPR‐RICTOR‐Liposomes | RICTOR | 4T1 | 174 |
miR‐125b | RLS/MNPs/miR‐125b | IRF4 | 4T1 | 176 |